Aplikacja GEn1E Lifesciences do YC

Summer 2019Active

GEn1E Lifesciences przeszedł przez Y Combinator w batchu Summer 2019 jako firma z branży Healthcare. Poniżej: czym zajmuje się firma, kto ją założył i jej aplikacja do YC, zrekonstruowana pytanie po pytaniu w prawdziwym formularzu YC.

Batch YC: Summer 2019
Branża: HealthcareTherapeutics
Status: Active
Wystartowano: 2022

Foundersi

Ritu LalFounder

Czym zajmuje się GEn1E Lifesciences

GEn1E Lifesciences is a Clinical-stage, multi-target company with a unique AI platform. We develop novel, next-generation, immunomodulatory therapies for rare & inflammatory diseases with no effective treatments. Our team is supercharging the drug development cycle by applying AI to multiple-mechanism-of-action protein targets and their natural platform capabilities - creating novel therapeutics at an unprecedented pace. Our AI platform has enabled us to develop a purpose-built therapy for ARDS to reduce its $20 billion cost on society (just in the USA). GEn1E has built a rich pipeline of 21+ novel and selective immunomodulators and has plans to accelerate 2 additional devastating diseases (beyond their lead indication) to IND in the next 12 months. Our AI platform enables tremendous pace and capital efficiency as demonstrated by our progress in ~2 years with seed capital - a stark contrast to the typical spend of $100M+ and 7+ years exhibited in the pharmaceuticals / biotech industry. With ~90% of rare diseases having no therapeutic treatment at all, GEn1E is taking a giant swing that will hopefully bring life-saving therapies to the lives of patients in need. The team at GEn1E has decades of experience in drug development and machine learning. We graduated from YCombinator and Stanford-StartX in late 2019. We are based in Palo Alto, CA.

Aplikacja GEn1E Lifesciences do YC, zrekonstruowana

Aplikacja Y Combinator

GEn1E Lifesciences, batch Summer 2019. Prawdziwe pytania z formularza, odpowiedzi na podstawie danych publicznych.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

GEn1E Lifesciences

Describe what your company does in 50 characters or less.

AI platform accelerating therapies for rare diseases

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI platform that speeds up discovery and development of novel immunomodulatory therapies targeting multiple mechanisms at once. Our platform identifies and optimizes protein therapies for rare and inflammatory diseases with no current treatments. We've already developed a lead candidate for ARDS and a pipeline of 21+ selective immunomodulators.

Where do you live now, and where would the company be based after YC?

We live in Palo Alto, CA, and the company is based here.

Explain your decision regarding location.

Palo Alto puts us at the center of biotech and AI innovation, with access to top talent, investors, and collaborators. It's also where we're rooted personally and professionally.

21 dodatkowych odpowiedzi w pełnej aplikacji

Są w pełnej wersji. Utwórz darmowe konto, aby otworzyć je w YC Insights, obok każdego innego batcha YC.

Zobacz pełną aplikację

Często zadawane pytania

Czy to jest prawdziwa aplikacja GEn1E Lifesciences do YC?

Nie. Y Combinator utrzymuje prywatność złożonych aplikacji. Jest to rekonstrukcja: prawdziwe pytania z formularza YC, na które odpowiedziano na podstawie publicznych danych GEn1E Lifesciences (notatki o premierze, tło founderów, opis produktu). Pokazuje, jak firma taka jak GEn1E Lifesciences przedstawiłaby się YC, a nie tekst, który złożyli.